SCHEMBL2980781

SCHEMBL2980781

O=c1cc[nH]c2ccc([N+](=O)[O-])cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.53
CA9 Q16790 2/20 0.53
PARP1 P09874 3/20 0.50
CTSV O60911 2/20 0.50
CTSL P07711 2/20 0.50
GRIA1 P42261 1/20 0.50
GRIA2 P42262 1/20 0.50
GRIA3 P42263 1/20 0.50
GRIA4 P48058 1/20 0.50
DAO P14920 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 1/20 0.47
LMNA P02545 1/20 0.47
HSP90AA1 P07900 1/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2993065 0.86 ALDH1A1 (0.56) CA12CA9PARP1CTSVCTSL
SCHEMBL30597526 0.77 MAPT (0.54) CA12CA9GRIA1GRIA2GRIA3
SCHEMBL28686 0.77 MAPT (0.54) CA12CA9GRIA1GRIA2GRIA3
SCHEMBL3299198 0.76 HSD17B10 (0.52) CA12CA9PARP1CTSVCTSL
Ammonia Solution, Strong SCHEMBL28394313 0.75 MAPT (0.53) CA12CA9GRIA1GRIA2GRIA3
Methane SCHEMBL27929615 0.75 MAPT (0.53) CA12CA9GRIA1GRIA2GRIA3
SCHEMBL155013 0.74 GABRA1 (0.70) CA12CA9PARP1CTSVCTSL
SCHEMBL29540314 0.74 GABRA1 (0.70) CA12CA9PARP1CTSVCTSL
SCHEMBL2512086 0.73 CYP3A4 (0.61) CA12CA9PARP1CTSVCTSL
SCHEMBL2993366 0.73 ALDH1A1 (0.60) CA12CA9PARP1CTSVCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173332-A1 Method for the Fluorescent Detection of Nitroreductase Activity Using Nitro-Substituted Aromatic Compounds AUCKLAND UNISERVICES LIMITED 2010-07-08 US claimed
CN-109456308-B Heterocyclic compounds as ASK inhibitors and their use 南京圣和药业股份有限公司 2022-11-29 CN disclosed
CN-105523996-B Amide derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2020-03-06 CN disclosed
CN-109456308-A Heterocyclic compound and its application as ASK inhibitor 南京圣和药业股份有限公司 2019-03-12 CN disclosed
CN-105523996-A Amide-type derivative and its preparation method and use in medicine JIANGSU HENGRUI MEDICINE CO 2016-04-27 CN disclosed
US-20100173332-A1 Method for the Fluorescent Detection of Nitroreductase Activity Using Nitro-Substituted Aromatic Compounds AUCKLAND UNISERVICES LIMITED 2010-07-08 US disclosed
WO-2008030120-A1 A METHOD FOR THE FLUORESCENT DETECTION OF NITROREDUCTASE ACTIVITY USING NITRO-SUBSTITUTED AROMATIC COMPOUNDS AUCKLAND UNISERVICES LIMITED (NZ) 2008-03-13 WO disclosed
WO-1997005114-A1 QUINOLONE SULFONIMIDES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION LABORATORIOS MENARINI S.A. (ES) 1997-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173332-A1 Method for the Fluorescent Detection of Nitroreductase Activity Using Nitro-Substituted Aromatic Compounds BLVRB, POR, CBR3 CA12 3288/4885CA9 2621/4885PARP1 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.